Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients.

BACKGROUND We conducted a prospective, uncontrolled, open study to assess the relationship between homocysteine (tHcy) and oxidative stress in chronic, stable, renal transplant recipients (RTR). METHODS Included in the study were 17 chronic, stable RTR. All the patients received folic acid (5 mg/day). tHcy and total antioxidant capacity (TAOC) were measured before and at the end of the study period. RESULTS Mean tHcy concentration was 26+/-10 micromol/L. tHcy significantly decreased during the study period (26+/-10 vs. 18+/-7 micromol/L; P<0.001). There was a significant inverse relationship between TAOC and tHcy (r= -0.33; P=0.01). TAOC significantly increased during the study period (1.49+/-0.23-1.78+/-0.6; P<0.001). There was an inverse relationship between the variation in tHcy and the variation in TAOC (r= -0.44; P=0.01). CONCLUSION Our results demonstrate that hyperhomocysteinemia contributed to increased oxidative stress in RTR. tHcy-lowering treatment with folic acid may lower oxidative stress.

[1]  H. Knapp,et al.  Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. , 1999, Circulation.

[2]  J. Morrow,et al.  Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[3]  D. Wilcken,et al.  Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[4]  S. Yusuf,et al.  Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence , 1999, Annals of Internal Medicine.

[5]  J. Kooner,et al.  Hyperhomocysteinemia : An Effect Reversible With Vitamin C Therapy Demonstration of Rapid Onset Vascular Endothelial Dysfunction After , 1999 .

[6]  P. Ueland,et al.  Elevated plasma levels of reduced homocysteine in common variable immunodeficiency — a marker of enhanced oxidative stress , 1997, European journal of clinical investigation.

[7]  I. Rosenberg,et al.  Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[8]  R. Gibey,et al.  Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. , 2000, Journal of the American Society of Nephrology : JASN.

[9]  Z. Massy,et al.  Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. , 1999, Kidney international.

[10]  J. Bonham,et al.  Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease. , 2001, Clinical science.